- $122.83m
- $98.88m
- CNY650.71m
Brief: Genetron Health Receives U.S. FDA Breakthrough Device Designation For Its Blood-Based Ngs Test For Early Detection Of Hepatocellular Carcinoma
Brief: Genetron Health And CStone Pharmaceuticals Announce Launch Of Clinical Trial In China For Companion Diagnostic Test In Development For Avapritinib
Brief: Genetron Health and dMed Announce Partnership
Brief: Genetron Holdings Q2 Loss Per Share $2.41
Brief: Genetron Health ADSS Open 0.9% Above IPO Price In Debut On The Nasdaq
Live Markets U.s.: IPO market still hot heading into summer
NASDAQ RESUMED AT 11:27 AM
NASDAQ RESUMED AT 11:07 AM
Brief: Genetron Health Announces Pricing Of Initial Public Offering
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM